Cannabis and sleep in older age

TL;DR

• Low-dose THC can shorten sleep onset but suppresses REM sleep.
• Discontinuation after prolonged use can trigger REM rebound and nightmares.
• CBD alone: mixed, generally weaker evidence for sleep.
• If sleep apnea is suspected, get medical assessment first.

What happens to sleep architecture?

Babson 2017 summarises: low-to-moderate THC doses shorten sleep latency and briefly boost deep sleep, but suppress REM sleep. Chronic use leads to tolerance to this effect; on discontinuation a REM rebound with intense dreams and fragmented sleep can occur — an important reason to taper slowly rather than stop abruptly.

Particular caution in older age

For obstructive sleep apnea the data is conflicting — some studies show possible worsening of respiratory regulation, making pre-treatment polysomnography sensible. Also, in older people the risk of morning hangover sedation rises, which is particularly relevant for driving.

The legal route to medical cannabis in Switzerland

Since the amendment to the law in August 2022, access to medical cannabis in Switzerland has become significantly easier for elderly patients. Previously, a tedious exceptional authorisation from the Federal Office of Public Health (BAG) was required, which deterred many patients from undergoing therapy. Today, qualified doctors can prescribe corresponding preparations directly on a narcotics prescription. This facilitation enables seniors to legally obtain standardised and quality-tested extracts from Swiss pharmacies, instead of resorting to the unregulated black market or untested products.

Prescriptions are usually written in the form of oily drops or capsules, which allows for precise dosing in the milligram range. This is particularly important in old age, as metabolism works more slowly and active substances are broken down with a delay. It is important to know that the compulsory health insurance does not automatically cover the costs of such therapy. Patients must submit a prior request for cost assumption to their health insurance company, which decides on coverage on a case-by-case basis. Without this approval, the often considerable costs for the magistral formulations must be borne by the patients themselves.

• Direct medical prescription via narcotics prescription has been possible since August 2022.
• Quality control through Swissmedic-certified pharmacy preparations guarantees exact active ingredient contents.
• Prior guarantee of cost coverage from the health insurance company is strongly recommended before starting therapy.
• Precise dosing thanks to standardised oily drops minimises the risk of overdosing.

Practical implementation and the principle of slow dosing

The practical application of cannabis to promote sleep in old age requires patience and a systematic approach. Since elderly people react more sensitively to psychoactive substances, the strict medical principle is «Start low, go slow». Therapy usually begins with a minimal dose in the evening, often just one to two drops of a standardised THC or combination oil. This dose is kept constant over several days to carefully monitor individual tolerance and the effect on sleep quality before a cautious adjustment is made in consultation with the specialist.

A common mistake in practice is increasing the dose too quickly or irregular intake. Since the effect of oral consumption via the gastrointestinal tract is delayed – often taking one to two hours to set in –, under no circumstances should an additional dose be taken on the same evening if there is no immediate effect. This inevitably leads to an accumulation of the active ingredients and increases the risk of undesirable side effects the following day. A detailed sleep diary helps to keep track of the time of intake, dosage, time falling asleep, and morning well-being in order to precisely determine the optimal therapeutic dose.

• Gradual dosing protects against undesirable psychoactive effects in old age.
• A delayed onset of action of up to two hours with oral intake must be planned for.
• Keeping a sleep diary to document dosage and well-being.
• No unauthorised dose increase on the same evening if there is no immediate effect.

Risks due to interactions and motor impairments

Elderly people often take multiple medications simultaneously, which massively increases the risk of dangerous interactions. Cannabinoids such as THC and CBD are broken down in the liver via the same enzyme systems as many common cardiovascular drugs, blood thinners, or antidepressants. This can cause the concentration of regular medications in the blood to rise or fall unpredictably. A careful medical assessment of all concurrently taken substances is therefore essential before the first intake of cannabis, in order to prevent toxic effects or a loss of efficacy of vital long-term medication.

In addition to chemical interactions, cannabinoids also pose physical risks in old age, particularly an increased risk of falls. THC can temporarily lower blood pressure and cause dizziness, especially when getting out of bed at night. Furthermore, muscle relaxation and a slight impairment of coordination can lead to a decrease in sure-footedness. To avoid nighttime falls and resulting fractures, seniors should only leave their bed with extreme caution after intake and ensure adequate lighting in the bedroom.

• Influence of cannabinoids on the breakdown of blood thinners, beta-blockers, and psychotropic drugs.
• Increased risk of falls when getting up at night due to orthostatic hypotension (drop in blood pressure).
• Possible impairment of motor coordination and reaction time the following day.
• Emergency contact for Tox Info Suisse (telephone 145) in case of suspected severe intolerance or overdose.

Fitness to drive and legal consequences in Swiss road traffic

For seniors who have remained mobile, the topic of fitness to drive under the influence of cannabis is of paramount importance. In Switzerland, a strict zero-tolerance policy regarding THC applies to road traffic. The legal limit is an extremely low 1.5 micrograms of THC per litre of blood serum. Since THC is stored in fatty tissue and is broken down much more slowly in older people due to changes in body composition and a slowed metabolism, this limit can still be exceeded days after the last consumption. Anyone found at the wheel with this level is legally considered unfit to drive.

Loss of the driving licence is almost always the consequence if the limit is proven to have been exceeded, regardless of whether there was any subjective impairment. Even with a medical prescription for medical cannabis, there is no automatic free pass to participate in road traffic. The treating physician must assess and certify the fitness to drive on an individual basis. As long as the titration phase is ongoing or the dose is being adjusted, the vehicle should strictly be left behind to avoid severe legal consequences and insurance recourse claims in the event of accidents.

• Strict limit of 1.5 micrograms of THC per litre of blood serum in Swiss road traffic.
• Slowed metabolism of the active substance in old age significantly extends its detectability in the blood.
• Medical prescription does not automatically exempt from the obligation of unfitness to drive.
• High risk of recourse claims by liability insurance in the event of accidents under the influence of THC.

FAQ